190 related articles for article (PubMed ID: 23835341)
1. Direct effects of TNF-α on local fuel metabolism and cytokine levels in the placebo-controlled, bilaterally infused human leg: increased insulin sensitivity, increased net protein breakdown, and increased IL-6 release.
Bach E; Nielsen RR; Vendelbo MH; Møller AB; Jessen N; Buhl M; K-Hafstrøm T; Holm L; Pedersen SB; Pilegaard H; Biensø RS; Jørgensen JO; Møller N
Diabetes; 2013 Dec; 62(12):4023-9. PubMed ID: 23835341
[TBL] [Abstract][Full Text] [Related]
2. Direct effects of locally administered lipopolysaccharide on glucose, lipid, and protein metabolism in the placebo-controlled, bilaterally infused human leg.
Buhl M; Bosnjak E; Vendelbo MH; Gjedsted J; Nielsen RR; K-Hafstrøm T; Vestergaard ET; Jessen N; Tønnesen E; Møller AB; Pedersen SB; Pilegaard H; Biensø RS; Jørgensen JO; Møller N
J Clin Endocrinol Metab; 2013 May; 98(5):2090-9. PubMed ID: 23543661
[TBL] [Abstract][Full Text] [Related]
3. Effects of adrenaline on lactate, glucose, lipid and protein metabolism in the placebo controlled bilaterally perfused human leg.
Gjedsted J; Buhl M; Nielsen S; Schmitz O; Vestergaard ET; Tønnesen E; Møller N
Acta Physiol (Oxf); 2011 Aug; 202(4):641-8. PubMed ID: 21624100
[TBL] [Abstract][Full Text] [Related]
4. Influence of TNF-alpha and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans.
Krogh-Madsen R; Plomgaard P; Møller K; Mittendorfer B; Pedersen BK
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E108-14. PubMed ID: 16464907
[TBL] [Abstract][Full Text] [Related]
5. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha.
Youd JM; Rattigan S; Clark MG
Diabetes; 2000 Nov; 49(11):1904-9. PubMed ID: 11078458
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle interleukin-6 and tumor necrosis factor-alpha release in healthy subjects and patients with type 2 diabetes at rest and during exercise.
Febbraio MA; Steensberg A; Starkie RL; McConell GK; Kingwell BA
Metabolism; 2003 Jul; 52(7):939-44. PubMed ID: 12870175
[TBL] [Abstract][Full Text] [Related]
7. Acute peripheral metabolic effects of intraarterial leg infusion of somatostatin in healthy young men.
Krusenstjerna-Hafstrøm T; Vestergaard ET; Buhl M; Nielsen R; Clasen BF; Nielsen S; Møller N; Pedersen SB; Jørgensen JO
J Clin Endocrinol Metab; 2011 Aug; 96(8):2581-9. PubMed ID: 21632809
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and increased muscle cytokine levels in patients with mitochondrial myopathy.
Rue N; Vissing J; Galbo H
J Clin Endocrinol Metab; 2014 Oct; 99(10):3757-65. PubMed ID: 25057876
[TBL] [Abstract][Full Text] [Related]
10. Short-term prednisone use antagonizes insulin's anabolic effect on muscle protein and glucose metabolism in young healthy people.
Short KR; Bigelow ML; Nair KS
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1260-8. PubMed ID: 19738036
[TBL] [Abstract][Full Text] [Related]
11. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle.
Steensberg A; Keller C; Starkie RL; Osada T; Febbraio MA; Pedersen BK
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1272-8. PubMed ID: 12388119
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness.
Carey AL; Bruce CR; Sacchetti M; Anderson MJ; Olsen DB; Saltin B; Hawley JA; Febbraio MA
Diabetologia; 2004 Jun; 47(6):1029-37. PubMed ID: 15168015
[TBL] [Abstract][Full Text] [Related]
13. Short-term insulin and nutritional energy provision do not stimulate muscle protein synthesis if blood amino acid availability decreases.
Bell JA; Fujita S; Volpi E; Cadenas JG; Rasmussen BB
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E999-1006. PubMed ID: 16030064
[TBL] [Abstract][Full Text] [Related]
14. Intact pituitary function is decisive for the catabolic response to TNF-α: studies of protein, glucose and fatty acid metabolism in hypopituitary and healthy subjects.
Bach E; Møller AB; Jørgensen JO; Vendelbo MH; Jessen N; Olesen JF; Pedersen SB; Nielsen TS; Møller N
J Clin Endocrinol Metab; 2015 Feb; 100(2):578-86. PubMed ID: 25375979
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of tumor necrosis factor-alpha reverses insulin resistance in skeletal muscle but not adipose tissue.
Borst SE; Lee Y; Conover CF; Shek EW; Bagby GJ
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E934-8. PubMed ID: 15213061
[TBL] [Abstract][Full Text] [Related]
16. Acute moderate elevation of TNF-alpha does not affect systemic and skeletal muscle protein turnover in healthy humans.
Petersen AM; Plomgaard P; Fischer CP; Ibfelt T; Pedersen BK; van Hall G
J Clin Endocrinol Metab; 2009 Jan; 94(1):294-9. PubMed ID: 18854397
[TBL] [Abstract][Full Text] [Related]
17. Tumour necrosis factor-alpha infusion produced insulin resistance but no change in the incretin effect in healthy volunteers.
Nielsen ST; Lehrskov-Schmidt L; Krogh-Madsen R; Solomon TP; Lehrskov-Schmidt L; Holst JJ; Møller K
Diabetes Metab Res Rev; 2013 Nov; 29(8):655-63. PubMed ID: 23904405
[TBL] [Abstract][Full Text] [Related]
18. Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue.
Krogh-Madsen R; Plomgaard P; Keller P; Keller C; Pedersen BK
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E234-8. PubMed ID: 14532168
[TBL] [Abstract][Full Text] [Related]
19. The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo.
Li L; Yang G; Shi S; Yang M; Liu H; Boden G
Cytokine; 2009 Jan; 45(1):12-9. PubMed ID: 19026557
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement.
Mingrone G; Rosa G; Di Rocco P; Manco M; Capristo E; Castagneto M; Vettor R; Gasbarrini G; Greco AV
Int J Obes Relat Metab Disord; 2002 Sep; 26(9):1165-72. PubMed ID: 12187392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
